Dasha Fomina, an equity analyst on William Blair Investment Management’s global equity team, was quoted in a Moneyweek story that focused on how consumers’ increased appetite for weight-loss drugs will reshape spending and investing patterns in the future.

These drugs change consumers’ habits and “make a profound impact on broader lifestyle choices in other areas – for example, by influencing alcohol and tobacco consumption,” Fomina told the publication.